Display options
Cite
Gong F, Li X, Zhang S, et al. A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome. Exp Ther Med. 2015;10(5):1865-1870doi: 10.3892/etm.2015.2769.
Gong, F., Li, X., Zhang, S., Ma, H., Cai, S., Li, J., Lin, G. E., & Lu, G. (2015). A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome. Experimental and therapeutic medicine, 10(5), 1865-1870. https://doi.org/10.3892/etm.2015.2769
Gong, Fei, et al. "A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome." Experimental and therapeutic medicine vol. 10,5 (2015): 1865-1870. doi: https://doi.org/10.3892/etm.2015.2769
Gong F, Li X, Zhang S, Ma H, Cai S, Li J, Lin GE, Lu G. A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome. Exp Ther Med. 2015 Nov;10(5):1865-1870. doi: 10.3892/etm.2015.2769. Epub 2015 Sep 23. PMID: 26640563; PMCID: PMC4665960.
Copy Download .nbib Format: NLM
Share it on

Exp Ther Med. 2015 Nov;10(5):1865-1870. doi: 10.3892/etm.2015.2769. Epub 2015 Sep 23.

A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome.

Experimental and therapeutic medicine

Fei Gong, Xihong Li, Shunji Zhang, Hainan Ma, Sufen Cai, Juan Li, G E Lin, Guangxiu Lu

Affiliations

  1. Institute of Reproductive and Stem Cell Engineering, Central South University, Changsha, Hunan 410083, P.R. China ; Department of Reproductive Medicine, Reproductive and Genetic Hospital of Citic-Xiangya, Changsha, Hunan 410078, P.R. China ; Key Laboratory of Human Stem Cell & Reproductive Engineering, Ministry of Health, Changsha, Hunan 410008, P.R. China.
  2. Department of Reproductive Medicine, Reproductive and Genetic Hospital of Citic-Xiangya, Changsha, Hunan 410078, P.R. China.

PMID: 26640563 PMCID: PMC4665960 DOI: 10.3892/etm.2015.2769

Abstract

There are currently various protocols for in vitro fertilization (IVF). For patients with polycystic ovarian syndrome (PCOS), an optimized protocol for the downregulation of pituitary follicle stimulating hormone and luteinizing hormone via gonadotropin-releasing hormone agonist (GnRHa) remains a challenge. In the present study, the primary endpoint of an ultra-long and a conventional long GnRHa protocol for intracytoplasmic sperm injection/IVF treatments of patients with PCOS was retrospectively compared. In the modified ultra-long protocol group, endometrial thickness, morphology, and blood flow were significantly improved, as compared with in the conventional long protocol group. Furthermore, the serum progestogen (P) concentrations and P/estrogen (E2) [(Px1,000/E2)] ratio on the day of human chorionic gonadotrophin administration were significantly decreased in the modified ultra-long downregulation group, whereas the pregnancy and implantation rates were significantly higher. There were no significant differences in the average number of obtained oocytes, good quality embryo rates, cancel rates, fertilization rates, abortion rates, serious ovarian hyperstimulation syndrome incidences, ectopic pregnancy rates or gonadotropin (Gn) dosages between the two groups. These results suggest that the modified ultra-long protocol plus human menopausal Gn medication may be superior to the conventional long protocol, and may lead to improved implantation and pregnancy outcomes for infertile patients with PCOS.

Keywords: endometrial receptivity; polycystic ovarian syndrome; ultra-long downregulation protocol

References

  1. Hum Reprod. 2012 Jun;27(6):1822-8 - PubMed
  2. Front Med China. 2010 Sep;4(3):280-4 - PubMed
  3. Reprod Biomed Online. 2012 Jan;24(1):6-22 - PubMed
  4. Hum Reprod. 2002 Jan;17(1):8-10 - PubMed
  5. Fertil Steril. 2002 Aug;78(2):245-51 - PubMed
  6. Fertil Steril. 2005 Feb;83(2):336-40 - PubMed
  7. J Assist Reprod Genet. 2010 Apr;27(4):149-55 - PubMed
  8. Hum Reprod. 2005 Jul;20(7):1867-75 - PubMed
  9. Ultrasound Obstet Gynecol. 2005 Dec;26(7):765-9 - PubMed
  10. Clin Med Res. 2004 Feb;2(1):13-27 - PubMed
  11. Hum Reprod. 2008 Aug;23(8):1835-9 - PubMed
  12. Curr Opin Obstet Gynecol. 2007 Dec;19(6):529-35 - PubMed
  13. Fertil Steril. 2011 Apr;95(5):1639-44 - PubMed
  14. Afr J Reprod Health. 2009 Mar;13(1):113-21 - PubMed
  15. Reprod Biomed Online. 2012 May;24(5):511-20 - PubMed
  16. Hum Reprod Update. 2013 Sep-Oct;19(5):433-57 - PubMed
  17. Reprod Biol Endocrinol. 2009 Apr 22;7:33 - PubMed
  18. Gynecol Endocrinol. 2010 Nov;26(11):833-7 - PubMed
  19. Fertil Steril. 2002 Oct;78(4):699-704 - PubMed
  20. J Assist Reprod Genet. 1999 Nov;16(10):523-8 - PubMed
  21. Fertil Steril. 2003 Dec;80(6):1444-9 - PubMed
  22. Fertil Steril. 2009 Jul;92(1):256-61 - PubMed
  23. Hum Reprod. 2002 Aug;17(8):2016-21 - PubMed
  24. J In Vitro Fert Embryo Transf. 1990 Jun;7(3):146-52 - PubMed
  25. Eur J Obstet Gynecol Reprod Biol. 2010 Jul;151(1):62-5 - PubMed
  26. Hum Reprod. 2004 Feb;19(2):330-8 - PubMed
  27. Eur J Obstet Gynecol Reprod Biol. 2005 Jun 1;120(2):179-84 - PubMed
  28. Reprod Biomed Online. 2007 Nov;15(5):532-8 - PubMed
  29. Gynecol Endocrinol. 2012 Jun;28(6):422-4 - PubMed
  30. Fertil Steril. 2002 Oct;78(4):757-62 - PubMed
  31. Hum Reprod. 2004 Jan;19(1):41-7 - PubMed

Publication Types